Related references
Note: Only part of the references are listed.The MEST score provides earlier risk prediction in IgA nephropathy
Sean J. Barbour et al.
KIDNEY INTERNATIONAL (2016)
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy
John Feehally et al.
NEPHRON (2016)
Randomized Controlled Trial of Mycophenolate Mofetil in Children, Adolescents, and Adults With IgA Nephropathy
Ronald J. Hogg et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Tonsillectomy for IgA Nephropathy: A Meta-analysis
Lin-lin Liu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
Thomas Rauen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis
Lesley A. Inker et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Comparison of Glucocorticoids Alone and Combined with Cyclosporine A in Patients with IgA Nephropathy: A Prospective Randomized Controlled Trial
Hong Liu et al.
INTERNAL MEDICINE (2014)
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
Rosanna Coppo et al.
KIDNEY INTERNATIONAL (2014)
Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
Junichiro Nakata et al.
PLOS ONE (2014)
IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine
Claudio Pozzi et al.
JOURNAL OF NEPHROLOGY (2013)
Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features
Gang Xin et al.
JOURNAL OF NEPHROLOGY (2013)
Is a legacy effect possible in IgA nephropathy?
Rosanna Coppo
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy
Yong-Chul Kim et al.
PLOS ONE (2013)
Efficacy and Safety of Mizoribine Combined With Losartan in the Treatment of IgA Nephropathy: A Multicenter, Randomized, Controlled Study
Yuansheng Xie et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)
Steroids and azathioprine in the treatment of IgA nephropathy
Maria Stangou et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2011)
Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy
Douglas D. McCarthy et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Predicting the Risk for Dialysis or Death in IgA Nephropathy
Francois Berthoux et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The Pathophysiology of IgA Nephropathy
Hitoshi Suzuki et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Genome-wide association study identifies susceptibility loci for IgA nephropathy
Ali G. Gharavi et al.
NATURE GENETICS (2011)
Addition of Azathioprine to Corticosteroids Does Not Benefit Patients with IgA Nephropathy
Claudio Pozzi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Sydney C. W. Tang et al.
KIDNEY INTERNATIONAL (2010)
Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis
Antonio Piccoli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Combination Therapy of Prednisone and ACE Inhibitor Versus ACE-Inhibitor Therapy Alone in Patients With IgA Nephropathy: A Randomized Controlled Trial
Jicheng Lv et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy
Carlo Manno et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy
Ali G. Gharavi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Remission of proteinuria improves prognosis in IgA nephropathy
Heather N. Reich et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy:: a double-blind randomized controlled trial
G Frisch et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy
S Tang et al.
KIDNEY INTERNATIONAL (2005)
Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial
C Pozzi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study
BD Maes et al.
KIDNEY INTERNATIONAL (2004)
Prognostic indicators of IgA nephropathy in the Chinese - clinical and pathological perspectives
PKT Li et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Share Paper
